MYOK
MyoKardia, Inc. Common Stock
MYOK
MYOK
Delisted
MYOK was delisted on the 16th of November, 2020.
128 hedge funds and large institutions have $1.47B invested in MyoKardia, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 51 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
12% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 51
49% less call options, than puts
Call options by funds: $6.21M | Put options by funds: $12.1M
Holders
128
Holding in Top 10
9
Calls
$6.21M
Puts
$12.1M
Top Buyers
1 | +$137M | |
2 | +$31.1M | |
3 | +$30.5M | |
4 |
HIM
Hillhouse Investment Management
Grand Cayman,
Cayman Islands
|
+$14.1M |
5 |
TCM
TimesSquare Capital Management
New York
|
+$12.5M |
Top Sellers
1 | -$97.6M | |
2 | -$39.8M | |
3 | -$32.8M | |
4 |
ACA
Avoro Capital Advisors
New York
|
-$16.8M |
5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$16.8M |